Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V.
Saved in:
| Title: | Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V. |
|---|---|
| Authors: | Gien, Lilian T.1 (AUTHOR) lilian.gien@sunnybrook.ca, Song, Zihe2 (AUTHOR), Poklepovic, Andrew3 (AUTHOR), Collisson, Eric A.4 (AUTHOR), Zwiebel, James A.5 (AUTHOR), Gray, Robert J.2 (AUTHOR), Wang, Victoria2 (AUTHOR), McShane, Lisa M.6 (AUTHOR), Rubinstein, Larry V.6 (AUTHOR), Patton, David R.7 (AUTHOR), Williams, P. Mickey8,9 (AUTHOR), Hamilton, Stanley R.10 (AUTHOR), Tricoli, James V.11 (AUTHOR), Conley, Barbara A.11 (AUTHOR), Arteaga, Carlos L.12 (AUTHOR), Harris, Lyndsay N.11 (AUTHOR), O'Dwyer, Peter J.13 (AUTHOR), Chen, Alice P.14 (AUTHOR), Flaherty, Keith T.15 (AUTHOR) |
| Source: | JCO Precision Oncology. 12/12/2024, Vol. 8, p1-9. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!